Currently holds positions in Aeolus Pharmaceuticals Inc and Tenax Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | Aeolus Pharmaceuticals Inc | June 28, 2004 - |
Independent Director | Tenax Therapeutics Inc | Dec. 15, 2011 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-15 | 2024-04-15 |
Fennec Pharmaceuticals Inc
(FENC)
|
S Sale |
800
-1.8%
10.458,360 USD |
800 -1.8% | 10.45 | 8,360 USD | |
2024-03-27 | 2024-03-26 |
Fennec Pharmaceuticals Inc
(FENC)
|
S Sale |
2,114
-4.9%
10.9723,191 USD |
2,114 -4.9% | 10.97 | 23,191 USD | |
2023-12-28 | 2023-12-26 |
Fennec Pharmaceuticals Inc
(FENC)
|
S Sale |
1,390
-3.0%
10.9015,151 USD |
1,390 -3.0% | 10.90 | 15,151 USD | |
2023-11-20 | 2023-11-20 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
269
-0.6%
8.252,219 USD |
269 -0.6% | 8.25 | 2,219 USD | |
2023-08-18 | 2023-08-18 |
Fennec Pharmaceuticals Inc
(FENC)
|
S Sale |
673
-1.5%
7.855,283 USD |
673 -1.5% | 7.85 | 5,283 USD | |
2023-07-24 | 2023-07-24 |
Fennec Pharmaceuticals Inc
(FENC)
|
S Sale |
6,796
-13.4%
8.1755,523 USD |
6,796 -13.4% | 8.17 | 55,523 USD | |
2023-07-06 | 2023-07-06 |
Fennec Pharmaceuticals Inc
(FENC)
|
S Sale |
2,207
-7.1%
8.4718,693 USD |
2,207 -7.1% | 8.47 | 18,693 USD | |
2023-05-19 | 2023-05-19 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
925
-2.9%
7.366,808 USD |
925 -2.9% | 7.36 | 6,808 USD | |
2023-05-19 | 2023-05-19 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
833
-2.5%
7.366,131 USD |
833 -2.5% | 7.36 | 6,131 USD | |
2022-11-17 | 2022-11-17 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
333
-1.1%
7.992,661 USD |
333 -1.1% | 7.99 | 2,661 USD |